EPISODE · Nov 21, 2025 · 35 MIN
NCPA 2025 Recap: Ownership, AI, and Surviving the MFP Cash Crunch
from The Bottom Line Pharmacy Podcast: Sykes & Company, P.A. · host Sykes & Company, P.A.
Send us Fan MailSchedule an Rx AssessmentSubscribe to Master The MarginHow will the Medicare Drug Price Negotiation Program reshape independent pharmacy? What should owners be doing now to prepare?In this episode of The Bottom Line Pharmacy Podcast, Scotty Sykes, CPA, CFP®, Bonnie Bond, CPA, and Austin Murray sit down in the new studio to recap NCPA 2025 from an ownership, cash flow, and strategy lens. We cover:- A 50,000-foot view of the Medicare Drug Price Negotiation Program- Key trends among startup vs. acquisition-minded owners- Pharmacy business plans and clinical servicesStay connected with us on social media:FacebookTwitterLinkedInInstagramMore on this topic:Podcast: The Trusted Pharmacist: Advocacy and Building a Resilient PharmacyPodcast: From Counter to Capitol
Embed this episode
What this episode covers
Send us Fan Mail Schedule an Rx Assessment Subscribe to Master The Margin How will the Medicare Drug Price Negotiation Program reshape independent pharmacy? What should owners be doing now to prepare? In this episode of The Bottom Line Pharmacy Podcast, Scotty Sykes, CPA, CFP®, Bonnie Bond, CPA, and Austin Murray sit down in the new studio to recap NCPA 2025 from an ownership, cash flow, and strategy lens. We cover: - A 50,000-foot view of the Medicare Drug Price Negotiation Program - Key...
NOW PLAYING
NCPA 2025 Recap: Ownership, AI, and Surviving the MFP Cash Crunch
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.